M&A Deal Summary

Sigma-Aldrich Acquires ChemNavigator

On August 7, 2009, Sigma-Aldrich acquired medical products company ChemNavigator from 3V SourceOne Capital

Acquisition Highlights
  • This is Sigma-Aldrich’s 1st transaction in the Medical Products sector.
  • This is Sigma-Aldrich’s 4th transaction in the United States.
  • This is Sigma-Aldrich’s 2nd transaction in Wisconsin.

M&A Deal Summary

Date 2009-08-07
Target ChemNavigator
Sector Medical Products
Buyer(s) Sigma-Aldrich
Sellers(s) 3V SourceOne Capital
Deal Type Add-on Acquisition

Target

ChemNavigator

Milwaukee, Wisconsin, United States
ChemNavigator, Inc. is a provider of drug discovery using proprietary proteomics and cheminformatics technologies, called 3-DPL™ Map and ChemMatrix™.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sigma-Aldrich

St. Louis, Missouri, United States

Category Company
Founded 1951
Sector Life Science
Employees9,800
Revenue 2.8B USD (2014)
DESCRIPTION

Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.


DEAL STATS #
Overall 7 of 13
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 5 of 9
State (Wisconsin) 2 of 2
Country (United States) 4 of 9
Year (2009) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-08 Molecular Medicine Bioservices

Carlsbad, California, United States

Molecular Medicine Bioservices, Inc. is a biopharmaceutical contract manufacturing organization to further enhance the biologics capabilities within its SAFC Pharma business segment.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-17 Ace Animals

Boyertown, Pennsylvania, United States

Ace Animals, Inc. provides high quality research rodents and contract breeding services to the pharmaceutical, biotech, life sciences and animal research industries.

Buy -

Seller(S) 1

DESCRIPTION

3V SourceOne Capital is a private equity firm focused on growth to late-stage investments in companies with an Asian link or growth strategy. This includes businesses in Southeast Asia, Greater China, and the US. 3V SourceOne does not have any sector preferences. 3V SourceOne Capital was formed in 2000 and is based in Singapore with an additional office in Saratoga, California.


DEAL STATS #
Overall 9 of 13
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 4 of 6
State (Wisconsin) 1 of 1
Country (United States) 5 of 8
Year (2009) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-23 EQUVO Pte

Singapore, Singapore

EQUVO Pte Ltd. is a provider of financial services, equipment management, consultancy and project management in the semiconductor, electronics, TFT/LCD & solar manufacturing industry.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-07 Omeros

Seattle, Washington, United States

Omeros is a clinical-stage bio-pharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, coagulopathies and disorders of the central nervous system. Omeros was founded in 1994 and is based in Seattle, Washington.

Sell -